Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 01/02/2012
PIL Lyrica Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/06/2011 and displayed until 01/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 13/09/2010 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to drug interactions
Updated on 29/06/2010 and displayed until 13/09/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 12/05/2010 and displayed until 29/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/03/2010 and displayed until 12/05/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/09/2009 and displayed until 01/03/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/01/2009 and displayed until 04/09/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/05/2008 and displayed until 16/01/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/03/2008 and displayed until 08/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 23/07/2007 and displayed until 25/03/2008
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to Further Information section
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 14/06/2007 and displayed until 23/07/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 07/02/2007 and displayed until 14/06/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Addition of Marketing Authorisation Holder
Updated on 25/09/2006 and displayed until 07/02/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Extra statutory information
  • Change to Marketing Authorisation Holder
  • Change to warnings or special precautions for use
Updated on 21/08/2006 and displayed until 25/09/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/06/2006 and displayed until 21/08/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to Further Information section
  • Change to date of revision
Updated on 21/04/2006 and displayed until 07/06/2006
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to drug interactions
  • Change to warnings or special precautions for use
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to side-effects
  • Change to storage instructions
  • Change to Further Information section
  • Correction of spelling/typing errors
  • Change to date of revision
Updated on 05/01/2006 and displayed until 21/04/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/07/2005 and displayed until 05/01/2006
Reasons for adding or updating:
  • Addition of joint PIL covering all presentations
  • Change to packaging
Updated on 10/05/2005 and displayed until 25/07/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 17/11/2004 and displayed until 10/05/2005
Reasons for adding or updating:
  • Change to packaging
Updated on 26/07/2004 and displayed until 17/11/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   pregabalin